UNSPSC 85257001: Diagnosis of neoplasm of uncertain behaviour on the bone and articular cartilage

This classification denotes the group of activities that yields a diagnosis of Neoplasm of uncertain or unknown behaviour on the Bone and articular cartilage. Neoplasm of uncertain or unknown behaviour on the Bone and articular cartilage is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D48.0

UNSPSC 85257001 Diagnosis of neoplasm of uncertain behaviour on the bone and articular cartilage is a Commodity code that does not align with the recent state and local procurement activity posted under it. The three most recent opportunities show no relevant connection to the code's nominal medical diagnostic scope: San Mateo Medical Center is soliciting an enterprise-grade diagnostic imaging PACS system with EPIC integration; Birdville Independent School District is requesting special education contracted services including audiologists and diagnosticians; and Santa Clara County Health System is establishing a qualified vendor pool for temporary health professional staffing across ancillary clinical categories. None of these solicitations addresses diagnosis of bone or cartilage neoplasm of uncertain behavior as a clinical service line or product category. The mismatch between the code's stated purpose and the actual work being tagged suggests the code sees little genuine procurement activity in state and local markets or that tagging has been applied inconsistently across jurisdictions.

The three opportunities represent different issuing bodies—a county public hospital system, an independent school district in Texas, and a county health system in California—with response dates between October 7 and October 21, 2026. Beyond these three records, the source provides no additional recent activity, geographic concentration, or issuing-body patterns that would clarify whether this code is routinely used for related clinical diagnostic services or remains largely inactive. Firms evaluating this code should confirm with procurement offices whether the tagging represents a systematic practice or an administrative error, and whether any real procurement volume exists under this or closely related diagnostic pathology codes.